R&G PharmaStudies Co. Ltd. A (301333) — Net Asset Momentum
R&G PharmaStudies Co. Ltd. A (301333) recorded a net asset momentum of 7.6% as of December 2025, with net assets of CN¥1.98 Billion CNY. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See how many days can R&G PharmaStudies Co. Ltd. A fund operations to measure how many days the company can operate on defensive assets alone.
YoY Momentum
Current Net Assets
Years of Data
Country
R&G PharmaStudies Co. Ltd. A Net Asset Momentum (2019–2025)
This chart tracks R&G PharmaStudies Co. Ltd. A's year-over-year net asset growth across 7 annual reporting periods from 2019 to 2025. The most recent momentum reading is +7.6%, with net assets of CN¥1.98 Billion CNY as of December 2025. Read R&G PharmaStudies Co. Ltd. A debt and liabilities for a breakdown of total debt and financial obligations.
Annual Net Asset History for R&G PharmaStudies Co. Ltd. A (2019–2025)
The table below shows the complete annual net asset history for R&G PharmaStudies Co. Ltd. A from 2019 to 2025, covering 7 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see how much is R&G PharmaStudies Co. Ltd. A worth.
| Year | Net Assets (CNY) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | CN¥1.98 Billion | CN¥2.40 Billion | CN¥423.89 Million | ▲ +7.6% |
| 2024 | CN¥1.84 Billion | CN¥2.34 Billion | CN¥500.09 Million | ▲ +4.6% |
| 2023 | CN¥1.75 Billion | CN¥2.07 Billion | CN¥319.17 Million | ▲ +10.1% |
| 2022 | CN¥1.59 Billion | CN¥1.88 Billion | CN¥289.35 Million | ▲ +264.0% |
| 2021 | CN¥437.81 Million | CN¥677.47 Million | CN¥239.66 Million | ▲ +29.9% |
| 2020 | CN¥336.98 Million | CN¥536.36 Million | CN¥199.38 Million | ▲ +34.9% |
| 2019 | CN¥249.74 Million | CN¥446.86 Million | CN¥197.12 Million | — |